WHO Names Members Of Advisory Committee On Human Genome Editing 14/02/2019 David Branigan The World Health Organization today announced the membership of its advisory committee that will assist in the development of global standards for the governance and oversight of human genome editing. Continue reading -> DNDi, MMV Make 400 Compounds Available To Boost Pandemic Disease Research 29/01/2019 William New The Drugs for Neglected Diseases initiative (DNDi) and Medicines for Malaria Venture (MMV) today announced the launch of the "Pandemic Response Box", which offers researchers free access to 400 compounds that could lead to development of new treatments for pandemic diseases. In return, researchers "will be expected to share data resulting from research on the molecules from the box in the public domain within 2 years of its generation." Continue reading -> WHO Director Lays Out Vision Of Transformation To ‘Agile’, Transparent Agency 24/01/2019 William New World Health Organization Director General Tedros Adhanom Ghebreyesus (Dr Tedros) today explained details of fundamental changes being set in motion at the UN agency, including greater impact, increased staff work and training at the country level, producing 'world class' work, more transparency, and digital health and innovation. In his opening remarks to the WHO Executive Board, he listed recent accomplishments and devoted significant attention to staffing issues at a time when unconfirmed reports of alleged misconduct have been circulating. Continue reading -> Introducing The New Health Policy Watch Website 23/01/2019 William New Today marks the launch of a brand-new online platform for Health Policy Watch, www.healthpolicy-watch.org, which has been redesigned to bring the richest possible selection of stories and ideas about current issues under debate in global health policy circles – which directly or indirectly touch the well-being of nearly everyone on the planet. Continue reading -> Top Global Health Policy Issues – What To Watch In 2019 23/01/2019 David Branigan When historians look back, will this year mark a turning point in global health? Certainly some of the big issues on the agenda in 2019 might suggest that we are at a crossroads. We can expect to see an intensification of the push for universal health coverage (UHC), culminating with a first-ever high-level United Nations meeting, and a shift away from disease-specific interventions towards more integrated approaches. Health Policy Watch spoke with a range of leading global health policy experts from the World Health Organization (WHO), NGOs, industry and foundations to get their take on the top issues, and here is what they said to watch for in 2019 in five priority areas. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Antibiotic R&D Group To Screen Pharma Chemical Libraries For Antibacterial Compounds 14/12/2018 David Branigan The Global Antibiotic Research and Development Partnership (GARDP) and the pharmaceutical companies Eisai and Takeda signed an agreement this week for GARDP to access and screen the chemical libraries of Eisai and Takeda with the hope of finding chemical compounds with antibacterial properties. Continue reading -> New Study Tracks Global Children’s Antibiotic Use, Finds Deviation From WHO Guidelines 07/12/2018 David Branigan A new study has analysed antibiotic sales data from 70 middle-income and high-income countries, and found variation in the use of antibiotics to treat children, with some countries deviating from World Health Organization recommendations on antibiotic stewardship. Continue reading -> WHO Publishes New Data, Finds Country Variations In Overuse, Misuse Of Antibiotics 12/11/2018 David Branigan The World Health Organization published new data today that it says “reveals wide differences in consumption of antibiotics in different countries,” suggesting overuse and misuse of these life-saving medicines, which contributes to antibiotic resistance. Continue reading -> Industry Coalition Tries To Get Out Front Of Antibiotic Resistance Efforts 12/11/2018 William New As governments increasingly mobilise to address the now-recognised urgency of creating new antibiotics before humanity develops resistance to existing ones, the pharmaceutical industry broadly is trying to position itself to be helpful in the effort. In a statement today, an industry alliance on antimicrobial resistance reported on its progress this year to date. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
DNDi, MMV Make 400 Compounds Available To Boost Pandemic Disease Research 29/01/2019 William New The Drugs for Neglected Diseases initiative (DNDi) and Medicines for Malaria Venture (MMV) today announced the launch of the "Pandemic Response Box", which offers researchers free access to 400 compounds that could lead to development of new treatments for pandemic diseases. In return, researchers "will be expected to share data resulting from research on the molecules from the box in the public domain within 2 years of its generation." Continue reading -> WHO Director Lays Out Vision Of Transformation To ‘Agile’, Transparent Agency 24/01/2019 William New World Health Organization Director General Tedros Adhanom Ghebreyesus (Dr Tedros) today explained details of fundamental changes being set in motion at the UN agency, including greater impact, increased staff work and training at the country level, producing 'world class' work, more transparency, and digital health and innovation. In his opening remarks to the WHO Executive Board, he listed recent accomplishments and devoted significant attention to staffing issues at a time when unconfirmed reports of alleged misconduct have been circulating. Continue reading -> Introducing The New Health Policy Watch Website 23/01/2019 William New Today marks the launch of a brand-new online platform for Health Policy Watch, www.healthpolicy-watch.org, which has been redesigned to bring the richest possible selection of stories and ideas about current issues under debate in global health policy circles – which directly or indirectly touch the well-being of nearly everyone on the planet. Continue reading -> Top Global Health Policy Issues – What To Watch In 2019 23/01/2019 David Branigan When historians look back, will this year mark a turning point in global health? Certainly some of the big issues on the agenda in 2019 might suggest that we are at a crossroads. We can expect to see an intensification of the push for universal health coverage (UHC), culminating with a first-ever high-level United Nations meeting, and a shift away from disease-specific interventions towards more integrated approaches. Health Policy Watch spoke with a range of leading global health policy experts from the World Health Organization (WHO), NGOs, industry and foundations to get their take on the top issues, and here is what they said to watch for in 2019 in five priority areas. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Antibiotic R&D Group To Screen Pharma Chemical Libraries For Antibacterial Compounds 14/12/2018 David Branigan The Global Antibiotic Research and Development Partnership (GARDP) and the pharmaceutical companies Eisai and Takeda signed an agreement this week for GARDP to access and screen the chemical libraries of Eisai and Takeda with the hope of finding chemical compounds with antibacterial properties. Continue reading -> New Study Tracks Global Children’s Antibiotic Use, Finds Deviation From WHO Guidelines 07/12/2018 David Branigan A new study has analysed antibiotic sales data from 70 middle-income and high-income countries, and found variation in the use of antibiotics to treat children, with some countries deviating from World Health Organization recommendations on antibiotic stewardship. Continue reading -> WHO Publishes New Data, Finds Country Variations In Overuse, Misuse Of Antibiotics 12/11/2018 David Branigan The World Health Organization published new data today that it says “reveals wide differences in consumption of antibiotics in different countries,” suggesting overuse and misuse of these life-saving medicines, which contributes to antibiotic resistance. Continue reading -> Industry Coalition Tries To Get Out Front Of Antibiotic Resistance Efforts 12/11/2018 William New As governments increasingly mobilise to address the now-recognised urgency of creating new antibiotics before humanity develops resistance to existing ones, the pharmaceutical industry broadly is trying to position itself to be helpful in the effort. In a statement today, an industry alliance on antimicrobial resistance reported on its progress this year to date. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Director Lays Out Vision Of Transformation To ‘Agile’, Transparent Agency 24/01/2019 William New World Health Organization Director General Tedros Adhanom Ghebreyesus (Dr Tedros) today explained details of fundamental changes being set in motion at the UN agency, including greater impact, increased staff work and training at the country level, producing 'world class' work, more transparency, and digital health and innovation. In his opening remarks to the WHO Executive Board, he listed recent accomplishments and devoted significant attention to staffing issues at a time when unconfirmed reports of alleged misconduct have been circulating. Continue reading -> Introducing The New Health Policy Watch Website 23/01/2019 William New Today marks the launch of a brand-new online platform for Health Policy Watch, www.healthpolicy-watch.org, which has been redesigned to bring the richest possible selection of stories and ideas about current issues under debate in global health policy circles – which directly or indirectly touch the well-being of nearly everyone on the planet. Continue reading -> Top Global Health Policy Issues – What To Watch In 2019 23/01/2019 David Branigan When historians look back, will this year mark a turning point in global health? Certainly some of the big issues on the agenda in 2019 might suggest that we are at a crossroads. We can expect to see an intensification of the push for universal health coverage (UHC), culminating with a first-ever high-level United Nations meeting, and a shift away from disease-specific interventions towards more integrated approaches. Health Policy Watch spoke with a range of leading global health policy experts from the World Health Organization (WHO), NGOs, industry and foundations to get their take on the top issues, and here is what they said to watch for in 2019 in five priority areas. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Antibiotic R&D Group To Screen Pharma Chemical Libraries For Antibacterial Compounds 14/12/2018 David Branigan The Global Antibiotic Research and Development Partnership (GARDP) and the pharmaceutical companies Eisai and Takeda signed an agreement this week for GARDP to access and screen the chemical libraries of Eisai and Takeda with the hope of finding chemical compounds with antibacterial properties. Continue reading -> New Study Tracks Global Children’s Antibiotic Use, Finds Deviation From WHO Guidelines 07/12/2018 David Branigan A new study has analysed antibiotic sales data from 70 middle-income and high-income countries, and found variation in the use of antibiotics to treat children, with some countries deviating from World Health Organization recommendations on antibiotic stewardship. Continue reading -> WHO Publishes New Data, Finds Country Variations In Overuse, Misuse Of Antibiotics 12/11/2018 David Branigan The World Health Organization published new data today that it says “reveals wide differences in consumption of antibiotics in different countries,” suggesting overuse and misuse of these life-saving medicines, which contributes to antibiotic resistance. Continue reading -> Industry Coalition Tries To Get Out Front Of Antibiotic Resistance Efforts 12/11/2018 William New As governments increasingly mobilise to address the now-recognised urgency of creating new antibiotics before humanity develops resistance to existing ones, the pharmaceutical industry broadly is trying to position itself to be helpful in the effort. In a statement today, an industry alliance on antimicrobial resistance reported on its progress this year to date. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Introducing The New Health Policy Watch Website 23/01/2019 William New Today marks the launch of a brand-new online platform for Health Policy Watch, www.healthpolicy-watch.org, which has been redesigned to bring the richest possible selection of stories and ideas about current issues under debate in global health policy circles – which directly or indirectly touch the well-being of nearly everyone on the planet. Continue reading -> Top Global Health Policy Issues – What To Watch In 2019 23/01/2019 David Branigan When historians look back, will this year mark a turning point in global health? Certainly some of the big issues on the agenda in 2019 might suggest that we are at a crossroads. We can expect to see an intensification of the push for universal health coverage (UHC), culminating with a first-ever high-level United Nations meeting, and a shift away from disease-specific interventions towards more integrated approaches. Health Policy Watch spoke with a range of leading global health policy experts from the World Health Organization (WHO), NGOs, industry and foundations to get their take on the top issues, and here is what they said to watch for in 2019 in five priority areas. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Antibiotic R&D Group To Screen Pharma Chemical Libraries For Antibacterial Compounds 14/12/2018 David Branigan The Global Antibiotic Research and Development Partnership (GARDP) and the pharmaceutical companies Eisai and Takeda signed an agreement this week for GARDP to access and screen the chemical libraries of Eisai and Takeda with the hope of finding chemical compounds with antibacterial properties. Continue reading -> New Study Tracks Global Children’s Antibiotic Use, Finds Deviation From WHO Guidelines 07/12/2018 David Branigan A new study has analysed antibiotic sales data from 70 middle-income and high-income countries, and found variation in the use of antibiotics to treat children, with some countries deviating from World Health Organization recommendations on antibiotic stewardship. Continue reading -> WHO Publishes New Data, Finds Country Variations In Overuse, Misuse Of Antibiotics 12/11/2018 David Branigan The World Health Organization published new data today that it says “reveals wide differences in consumption of antibiotics in different countries,” suggesting overuse and misuse of these life-saving medicines, which contributes to antibiotic resistance. Continue reading -> Industry Coalition Tries To Get Out Front Of Antibiotic Resistance Efforts 12/11/2018 William New As governments increasingly mobilise to address the now-recognised urgency of creating new antibiotics before humanity develops resistance to existing ones, the pharmaceutical industry broadly is trying to position itself to be helpful in the effort. In a statement today, an industry alliance on antimicrobial resistance reported on its progress this year to date. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Top Global Health Policy Issues – What To Watch In 2019 23/01/2019 David Branigan When historians look back, will this year mark a turning point in global health? Certainly some of the big issues on the agenda in 2019 might suggest that we are at a crossroads. We can expect to see an intensification of the push for universal health coverage (UHC), culminating with a first-ever high-level United Nations meeting, and a shift away from disease-specific interventions towards more integrated approaches. Health Policy Watch spoke with a range of leading global health policy experts from the World Health Organization (WHO), NGOs, industry and foundations to get their take on the top issues, and here is what they said to watch for in 2019 in five priority areas. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Antibiotic R&D Group To Screen Pharma Chemical Libraries For Antibacterial Compounds 14/12/2018 David Branigan The Global Antibiotic Research and Development Partnership (GARDP) and the pharmaceutical companies Eisai and Takeda signed an agreement this week for GARDP to access and screen the chemical libraries of Eisai and Takeda with the hope of finding chemical compounds with antibacterial properties. Continue reading -> New Study Tracks Global Children’s Antibiotic Use, Finds Deviation From WHO Guidelines 07/12/2018 David Branigan A new study has analysed antibiotic sales data from 70 middle-income and high-income countries, and found variation in the use of antibiotics to treat children, with some countries deviating from World Health Organization recommendations on antibiotic stewardship. Continue reading -> WHO Publishes New Data, Finds Country Variations In Overuse, Misuse Of Antibiotics 12/11/2018 David Branigan The World Health Organization published new data today that it says “reveals wide differences in consumption of antibiotics in different countries,” suggesting overuse and misuse of these life-saving medicines, which contributes to antibiotic resistance. Continue reading -> Industry Coalition Tries To Get Out Front Of Antibiotic Resistance Efforts 12/11/2018 William New As governments increasingly mobilise to address the now-recognised urgency of creating new antibiotics before humanity develops resistance to existing ones, the pharmaceutical industry broadly is trying to position itself to be helpful in the effort. In a statement today, an industry alliance on antimicrobial resistance reported on its progress this year to date. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Antibiotic R&D Group To Screen Pharma Chemical Libraries For Antibacterial Compounds 14/12/2018 David Branigan The Global Antibiotic Research and Development Partnership (GARDP) and the pharmaceutical companies Eisai and Takeda signed an agreement this week for GARDP to access and screen the chemical libraries of Eisai and Takeda with the hope of finding chemical compounds with antibacterial properties. Continue reading -> New Study Tracks Global Children’s Antibiotic Use, Finds Deviation From WHO Guidelines 07/12/2018 David Branigan A new study has analysed antibiotic sales data from 70 middle-income and high-income countries, and found variation in the use of antibiotics to treat children, with some countries deviating from World Health Organization recommendations on antibiotic stewardship. Continue reading -> WHO Publishes New Data, Finds Country Variations In Overuse, Misuse Of Antibiotics 12/11/2018 David Branigan The World Health Organization published new data today that it says “reveals wide differences in consumption of antibiotics in different countries,” suggesting overuse and misuse of these life-saving medicines, which contributes to antibiotic resistance. Continue reading -> Industry Coalition Tries To Get Out Front Of Antibiotic Resistance Efforts 12/11/2018 William New As governments increasingly mobilise to address the now-recognised urgency of creating new antibiotics before humanity develops resistance to existing ones, the pharmaceutical industry broadly is trying to position itself to be helpful in the effort. In a statement today, an industry alliance on antimicrobial resistance reported on its progress this year to date. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Antibiotic R&D Group To Screen Pharma Chemical Libraries For Antibacterial Compounds 14/12/2018 David Branigan The Global Antibiotic Research and Development Partnership (GARDP) and the pharmaceutical companies Eisai and Takeda signed an agreement this week for GARDP to access and screen the chemical libraries of Eisai and Takeda with the hope of finding chemical compounds with antibacterial properties. Continue reading -> New Study Tracks Global Children’s Antibiotic Use, Finds Deviation From WHO Guidelines 07/12/2018 David Branigan A new study has analysed antibiotic sales data from 70 middle-income and high-income countries, and found variation in the use of antibiotics to treat children, with some countries deviating from World Health Organization recommendations on antibiotic stewardship. Continue reading -> WHO Publishes New Data, Finds Country Variations In Overuse, Misuse Of Antibiotics 12/11/2018 David Branigan The World Health Organization published new data today that it says “reveals wide differences in consumption of antibiotics in different countries,” suggesting overuse and misuse of these life-saving medicines, which contributes to antibiotic resistance. Continue reading -> Industry Coalition Tries To Get Out Front Of Antibiotic Resistance Efforts 12/11/2018 William New As governments increasingly mobilise to address the now-recognised urgency of creating new antibiotics before humanity develops resistance to existing ones, the pharmaceutical industry broadly is trying to position itself to be helpful in the effort. In a statement today, an industry alliance on antimicrobial resistance reported on its progress this year to date. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New Study Tracks Global Children’s Antibiotic Use, Finds Deviation From WHO Guidelines 07/12/2018 David Branigan A new study has analysed antibiotic sales data from 70 middle-income and high-income countries, and found variation in the use of antibiotics to treat children, with some countries deviating from World Health Organization recommendations on antibiotic stewardship. Continue reading -> WHO Publishes New Data, Finds Country Variations In Overuse, Misuse Of Antibiotics 12/11/2018 David Branigan The World Health Organization published new data today that it says “reveals wide differences in consumption of antibiotics in different countries,” suggesting overuse and misuse of these life-saving medicines, which contributes to antibiotic resistance. Continue reading -> Industry Coalition Tries To Get Out Front Of Antibiotic Resistance Efforts 12/11/2018 William New As governments increasingly mobilise to address the now-recognised urgency of creating new antibiotics before humanity develops resistance to existing ones, the pharmaceutical industry broadly is trying to position itself to be helpful in the effort. In a statement today, an industry alliance on antimicrobial resistance reported on its progress this year to date. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Publishes New Data, Finds Country Variations In Overuse, Misuse Of Antibiotics 12/11/2018 David Branigan The World Health Organization published new data today that it says “reveals wide differences in consumption of antibiotics in different countries,” suggesting overuse and misuse of these life-saving medicines, which contributes to antibiotic resistance. Continue reading -> Industry Coalition Tries To Get Out Front Of Antibiotic Resistance Efforts 12/11/2018 William New As governments increasingly mobilise to address the now-recognised urgency of creating new antibiotics before humanity develops resistance to existing ones, the pharmaceutical industry broadly is trying to position itself to be helpful in the effort. In a statement today, an industry alliance on antimicrobial resistance reported on its progress this year to date. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Industry Coalition Tries To Get Out Front Of Antibiotic Resistance Efforts 12/11/2018 William New As governments increasingly mobilise to address the now-recognised urgency of creating new antibiotics before humanity develops resistance to existing ones, the pharmaceutical industry broadly is trying to position itself to be helpful in the effort. In a statement today, an industry alliance on antimicrobial resistance reported on its progress this year to date. Continue reading -> Posts navigation Older postsNewer posts